The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Lipid-Mediated Enhancement of Transfection by a Nonviral Integrin-Targeting Vector
Abstract
Nonviral vectors consisting of integrin-targeting peptide/DNA (ID) complexes have the potential for widespread application in gene therapy. The transfection efficiency of this vector, however, has been limited by endosomal degradation. We now report that lipofectin (L) incorporated into the ID complexes enhances integrin-mediated transfection, increasing Iuciferase expression by more than 100-fold. The transfection efficiency of Lipofectin/Integrin-binding peptide/DNA (LID) complexes, assessed by β-galactosidase reporter gene expression and X-gal staining, was improved from 1% to 10% to over 50% for three different cell lines, and from 0% to approximately 25% in corneal endothelium in vitro. Transfection complexes have been optimized with respect to their transfection efficiency and we have investigated their structure, function, and mode of transfection. Both ID and LID complexes formed particles, unlike the fibrous network formed by lipofectin/DNA complexes (LD). Integrin-mediated transfection by LID complexes was demonstrated by the substantially lower transfection efficiency of LKD complexes in which the integrin-biding peptide was substituted for K16 (K). Furthermore, the transfection efficiency of complexes was shown to be dependent on the amount of integrin-targeting ligand in the complex. Finally, a 34% reduction in integrin-mediated transfection efficiency by LID complexes was achieved with a competing monoclonal antibody. The role of lipofectin in LID complexes appears, therefore, to be that of a co-factor, enhancing the efficiency of integrin-mediated transfection. The mechanism of enhancement is likely to involve a reduction in the extent of endosomal degradation of DNA. Nonviral vectors, consisting of a targeting ligand and a DNA-binding moiety, have great potential for gene therapy due to their safety, simplicity, and capacity for packaging very large DNA molecules. The major limiting factor in the development and application of these vectors, however, has been poor transfection efficiency due, primarily, to endosomal degradation. We have developed an integrin-targeted vector, consisting of a peptide containing a 16-lysine DNA-binding domain and one of a number of possible integrin-binding domains, of approximately 10 amino acid residues. Complexes of peptide and plasmid DNA transfect a number of different cells. The efficiency of this vector has now been enhanced substantially by incorporating small amounts of lipofectin into the complexes. Transfection is largely integrin mediated and the enhancement effect may be explained by lipofectin destabilizing endosomal membranes. Lipofectin-mediated enhancement may be a general approach to improving the efficiency of receptor-mediated vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library.
Koivunen, E., Gay, D. A., & Ruoslahti, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80715-7 · Cited by 344
Massia, S. P., & Hubbell, J. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49672-5 · Cited by 287
Cited by
Papafili, A., Hill, M. R., Brull, D. J., McAnulty, R. J., Marshall, R. P., Humphries, S. E., & Laurent, G. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000030340.80207.c5 · Cited by 342
S URFACE B IOLOGY OF DNA BY A TOMIC F ORCE M ICROSCOPY
Hansma, H. G. (2001) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.52.1.71 · Cited by 279
Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
Rezaee, M., Oskuee, R. K., Nassirli, H., & Malaekeh-Nikouei, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.023 · Cited by 200
Metadata
- Authors
- Hart, S. L., Arancibia-Cárcamo, C. V., Wolfert, M. A., Mailhos, C., O'reilly, N. J., Ali, R. R., Coutelle, C., George, A. J. T., Harbottle, R. P., Knight, A. M., Larkin, D. F. P., Levinsky, R. J., Seymour, L. W., Thrasher, A. J., & Kinnon, C.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1998-03
- Volume
- 9
- Issue
- 4
- Pages
- 575-585
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2023848643
- Cited by
- 176
- References
- 2
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.